Results

Total Results: 2,463 records

Showing results for "testing".

321. Gout Executive-2016 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
     January 01, 2016 - analysis • Type of provider aspirating joint • Type of provider assessing fluid Diagnostic Testing … Key Question 2 assesses potential adverse effects that might be associated with testing: short- and … dotted lines indicate possible outcomes; for example, diagnostic accuracy and adverse effects of testing … they addressed Key Question 2 (adverse events or other negative outcomes in individuals undergoing testing … In addition, specific elements of the criteria, such as hyperuricemia, require additional testing.

322. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
     February 01, 2006 - Layout 1 Background Breast cancer is the second most common malignancy in women. The American Cancer Society estimated that in the United States in 2005, 212,930 women would be newly diagnosed as having breast cancer and there would be 40,870 deaths due to this disease. Because early breast cancer is asymptomatic, th…

323. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
     January 01, 2011 - stems from inadequate diet and absorption, procedure-related iron losses from repeated laboratory testing … What are the adverse effects or harms associated with testing using newer and/or older markers of iron … o Adverse effects or harms associated with testing and associated treatments (e.g., test- related anxiety … iron -Transferrin saturation -Iron-binding capacity -Ferritin Adverse events related to lab testing … A randomized trial of iron deficiency testing strategies in hemodialysis patients.

324. Imaging for Pretreatment Staging of Small Cell Lung Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/lung-cancer-staging/research-protocol
     December 08, 2014 - Testing for recurrent small cell lung cancer will be excluded.

325. Prostate-Cancer-Risk-Assessment-Genes Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
     July 01, 2012 - asymptomatic men).14 A meta- analysis of seven randomized controlled trials of screening using PSA testing … Companies known to offer testing for the risk of prostate cancer based on SNP panels were approached … in May of 2011, as were companies known to offer genetic testing more generally. … Risks and benefits of population-based genetic testing for Mendelian subsets of common diseases were … Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes.

326. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
     December 20, 2011 - of diffuse literature on the subject, especially with regard to the utility of BNP or NT-pro-BNP testing … Indeed, all potential areas of use for BNP and NT-pro-BNP testing require clarification using currently … Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. … N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on … Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure:

327. Colorectal-Cancer-Staging Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_executive.pdf
     September 01, 2014 - screening for colorectal cancer in asymptomatic normal-risk individuals using fecal occult blood testing … has been established, patients with colorectal cancer undergo Effective Health Care Program 2 testing … additional treatment, including surgery, radiotherapy, or chemotherapy – Resource use related to testing … and treatment • Adverse effects and harms – Harms of testing per se (e.g., radiation exposure) … For questions about the impact of testing on patient-oriented clinical outcomes, we considered comparative

328. Gout Dx protocol_140715-draft (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
     January 01, 2014 - comments and input from the Technical Expert Panel (TEP) for the review on diagnosis of gout, the testing … Additional testing ! Pharmacologic/dietary management o Intermediate outcomes ! sUA !

329. Translation of a C. difficile Treatment Clinical Pathway Into Machine-Readable Clinical Decision Support Artifacts Prototyped for Electronic Health Record Implementation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
     November 01, 2019 - O= Order, C= Consider, D= Diagnosis, M= Monitor, L= Laboratory Testing, R= Recommendation Task 2. … In the software development lifecycle, this stage of testing is often referred to as “black box” testing … The CDS Connect Authoring Tool provides support for unit testing (testing of combinations of patient … We recommend that AHRQ consider developing an EHR testing environment to facilitate testing and quality … Extent of Adherence to Trustworthy Standards (NEATS) InstrumentDeveloping and Testing NEATS.

330. Methods Research Report: Performance and Usability of Machine Learning for Screening in Systematic Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-machine-learning-screening.pdf
     November 01, 2019 - Screening Exercise for the User Experiences Testing Appendix B. … Key differences between the tools played an important role in the user experience testing by exposing … We received ethical approval to complete the user experience testing from the University of Alberta … Before beginning the user experience testing, the screening exercise and survey were pilot tested by … Screening Exercise for the User Experiences Testing Screening Exercise Instructions for Each Tool

331. Efficacy and Safety of Screening for Postpartum Depression | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/depression-postpartum-screening/research
     April 09, 2013 - Modeling suggests that serial testing with a two-question screen followed by a second more specific instrument

332. Ch 3-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
     September 21, 2012 - If we make a Bonferroni correction for multiple testing in order to maintain the correct Type-I error … biological and epidemiological evidence; detailed description of a statistical analysis plan for how testing … achieve Possible Difficult to characterize sampling properties (e.g., confidence intervals) Power of testing … To do this, chance findings should be evaluated by testing for interaction; biases should be avoided … - Describe methods to adjust for multiple testing, if applicable. o Describe how confounding

333. Product Search | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products?f%5B0%5D=field_product_type%3Aresearch_report&f%5B1%5D=field_product_type%3Asystematic_review&f%5B2%5D=field_product_type%3Atechnical_brief&sort_by=field_product_pub_date
     September 20, 2021 - , and Opioid Use Disorder in Older Adults Technical Brief November 3, 2020 Testing

334. AHRQ’s Evidence-based Practice Center Program: Synthesizing evidence to improve health care practice and delivery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-health-care-practice-delivery.pdf
     November 01, 2022 - , treatments for depression, management of opioid overdose) ◆ Diagnostic tests (e.g., noninvasive testing

335. Comparative Effectiveness of Screening for Glaucoma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/glaucoma-screening/research-protocol
     November 16, 2010 - field loss may be impractical for population-based screening because of the length of time required for testing … conducted alone or in any possible combination (including multicomponent simultaneous or sequential testing

336. breast-biopsy-update-130920 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_research-protocol.pdf
     September 20, 2013 - results, including interlaboratory initiatives to standardize diagnostic criteria (e.g., proficiency testing … to be combined in a meta-analysis on the basis of clinical heterogeneity of patient populations and testing … For patient populations (e.g., women at “average risk”), testing methods, and outcomes in cases where

337. Disposition of Comments Technical Brief 41: Evaluation of Mental Health Mobile Applications (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-mobile-apps-disposition-of-comments.pdf
     May 20, 2022 - Pilot testing with 10 apps is inadequate (possible bias in app selection); more detail is needed on … The section on pilot testing has been revised based on results from further rounds of testing. … The final report describes the pre-pilot test of 10 apps and six rounds of dual-review pilot testing … We have reported the interrater reliability for the additional rounds of pilot testing, which is … However, during the pilot testing phase, we were unable to test the framework on apps that could

338. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
     May 24, 2010 - • Timing: Diagnostic testing: time to test http://www.effectivehealthcare.ahrq.gov/� … Provisional framework for diagnostic testing and treatment Testing for recurrence Nursing

339. Effectiveness of Screening and Treatment of C. difficile Infections | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/c-diff-infections/research-protocol
     May 24, 2010 - Timing: Diagnostic testing: time to test Antibiotic and non-standard treatments: variable, generally … Provisional framework for diagnostic testing and treatment Figure 2.

340. Protocol: Imaging for Pretreatment Staging of Small Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
     December 08, 2014 - Testing for recurrent small cell lung cancer will be excluded. d.